[Detection of NK and NKT cells in peripheral blood of patients with cGVHD and its significance].

The aim of this study was to investigate the correlation of NK and NKT cells in peripheral blood of patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) with chronic graft-versus-host disease (cGVHD). 64 patients undergoing allo-HSCT in Guangdong Provincial People Hospital were studied retrospectively. Among 64 cases, 21 cases were did not develop with cGVHD, 43 cases (mild 15, moderate 18, severe 10) were recorded with cGVHD. The frequency of NK and NKT cells in peripheral blood of patients were measured by flow cytometry. The counts of NK and NKT cells were measured by automatic five sort hematology cyto-analyser (LH-750). The frequency and counts of NK and NKT cells between patients with non-cGVHD and patients with different status of cGVHD were analysed. The results indicated that as compared with the non-cGVHD patients, the frequency and counts of NK cells in patients with cGVHD obviously reduced (P < 0.05), the frequency and count of NKT cells were did not changed significantly. The frequency and counts of NK cells gradually decreased within the different status of cGVHD, the frequency and counts of NK cells in severe-cGVHD were significantly lower than that in mild-cGVHD. It is concluded that NK cells may play an important role in the incidence and development of cGVHD. The detection of frequency and counts of NK cells should be helpful to early diagnose cGVHD and provide valuable clues for assessing the severity of illnesses. NKT cells may have little effect on the incidence and development of cGVHD.

[Prenatal diagnosis of ß-thalassaemia using cell-free fetal DNA in maternal plasma].

OBJECTIVE: To investigate the clinical feasibility of cell-free fetal DNA (cffDNA)-based noninvasive prenatal diagnosis of ß-thalassemia. METHODS: Nine samples of amniotic fluid were obtained to detect the 8 common and 9 relatively rare mutation sites of ß-thalassaemia in Guangdong Province. The maternal blood samples were also collected for extracting and purification of the cffDNA, and a duplex PCR was performed using 3 pairs of primers and the fetal ß-globin genotype was analyzed by reverse dot-blot hybridization. RESULTS: Among the 9 cases, 5 showed fetal genotypes of ß-thalassemia inherited from the father by examination of the amniotic fluid, and 2 fetuses were identified to have ß-thalassemia genes inherited from the father determined based on the cffDNA in the maternal blood. CONCLUSIONS: The cffDNA-based noninvasive prenatal diagnosis is feasible for ß-thalassemia, but the contamination of the maternal background DNA results in a low detection rate.